-
In this issue: New recommendations for HPV vaccine; guidelines for treatment of essential tremor; updates on smoking cessation drugs; and FDA actions.
-
The objective of this study was to estimate the use of vte prophylaxis in women undergoing major gynecologic surgery and to estimate the patient, physician, and hospital characteristics associated with their use.
-
The author informs us that the winner of the 2010 Tour de France was Alberto Contador, riding a Specialized SL3 racing bike. The U.S. rider Chris Horner finished 12 minutes behind riding a Trek, Madone. The best rookie finisher, Daniel Loyd, rode a Cervelo S3, and finished more than 4 hours behind the leaders.
-
In an otherwise normal preterm pregnancy, is oligohydramnios a reason to deliver? This question has popped up repeatedly, and an article in the September issue of the American Journal of Obstetrics and Gynecology addressed this conundrum.
-
-
As U.S. waistlines continue to grow, so does the concern regarding obesity's effects on health and health care.
-
If your clinical practice includes the care of age 50-plus women, are you including information on risks for sexually transmitted infections (STIs)? You should.
-
According to the Centers for Disease Control and Prevention, female adolescents have the highest number of cases of gonorrhea and chlamydia in the United States.1 While the overall prevalence for these infections among individuals ages 14-39 are .24% and 2.2% respectively, these rates are .92% and 3.4% for those ages 14-19.2
-
The Food and Drug Administration (FDA) has scheduled a Dec. 8, 2011, meeting of its Reproductive Health Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee to review the risks and benefits of oral contraceptives containing the progestin drospirenone. The agency is weighing evidence regarding the risk of increased blood clots in users of such pills.
-
Thyroid dysfunction and disease might present as reproductive compromise including oligomenorrhea, infertility, and miscarriage.